Zelboraf May Double Survival for Some Melanoma Patients

The newly approved drug Zelboraf appears to nearly double the length of time a person can expect to live with advanced melanoma skin cancer, a new study shows.

Source: http://www.webmd.com/melanoma-skin-cancer/news/20120222/zelboraf-may-double-survival-for-some-melanoma-patients?src=RSS_PUBLIC

health and fitness diet low fat diet